adaptive immunity 6 .
αGalCer has been shown to have adjuvant-like properties that enhance Tdependent and T-independent humoral immune responses [7] [8] [9] [10] . In order to generate antibodies to T-dependent antigens, B cells require cognate T cell help from conventional T helper (Th) cells that recognize the same antigen or antigenic complex which has been internalized by the B cell receptor (BCR). αGalCer has been shown to boost dendritic cell (DC)-Th interactions that augment Th priming and indirectly promote B cell help 11 .
However, B cells also express CD1d and have been shown to present lipid antigens and recruit cognate help from NKT cells 8, 9, 12, 13 .
Recent work has shown that BCR-mediated uptake of model B cell antigens linked to αGalCer elicits cognate NKT help for lipid-specific B cell responses in vivo and in vitro [12] [13] [14] . However, B cells also internalize and present lipid antigens to NKT cells by pathways that are independent of the BCR 15 
Materials and Methods: NKT cells:
Two CD1d-restricted human NKT cell clones (BM2a.3 and J3N.5, previously described 17 and one CD1d-restricted human NKT line (M0) were used in these studies and similar results were obtained. M0 was derived by successive rounds of αGalCer-CD1d-tetramer sorting and expansion with αGalCer, with a resulting population of T cells that are >99% CD4 positive, >95% Valpha24/V beta 11 (double positive), and >97% αGalCer-CD1d-tetramer positive. NKT cells were maintained in RPMI media (supplemented with 10% FBS (Hyclone, Logan, UT), 2% human AB serum (MP Biomedical), penicillin/streptomycin, and 200 U/ml IL-2) and re-stimulated every 17-30 days using PHA and irradiated PBMC obtained from healthy volunteers.
B cell isolation:
Tonsils were obtained from anonymous patients undergoing tonsillectomy at BC Ilarionov and Dr. Gurdyal Besra) were incubated for 10mins with SFM alone or SFM plus 2.5 μg/ml fractionated apoE (Meridian), or recombinant apoE (rApoE2, rApoE3 or rApoE4 from Invitrogen), or with 5% fresh human serum prior to addition to cells. PHA (Sigma-Aldrich) was used as a positive control. The concentration of apoE used was optimized as described previously 16 , and reflects of the concentration found in typical serum containing media. Where indicated, blocking antibodies including anti-CD1d (12 μg/ml, clone 12.1.1.1 18 ), goat polyclonal anti-LDL-R (5 μg/ml, R&D), monoclonal anti-LDL-R (4 μg/ml clone IgG-C7; Biodesign, Saco, ME) or equal amount of corresponding isotype control antibodies (mIgG 1 , goat IgG, and mIgG 2b respectively) were used. The next day, culture supernatants were harvested and T cell IFN-γ production by was measured by capture ELISA using anti-IFN-γ capture antibody (2G1) and biotin labeled anti-IFN-γ (B133.5) detection antibody (both from Thermo Scientific, Rockford, IL).
Lipid uptake experiments were performed by pulsing CD40L-activated B cells for 4 hours in media alone or with lipid antigens with or without 2.5 μg/ml apoE. Cells were washed prior to being cultured with NKT cells in SFM overnight as described above.
Antibodies and Flow Cytometry. Flow cytometry was performed on FACScalibur (BD) and data was analyzed using FlowJo (Ashland, OR).
Statistical Analysis
Statistical analysis was performed using the paired Student's t-test or by ANOVA using EXCEL or PRISM software. Asterisks are used to indicate significant results (*p<0.05 and **p<0.001) compared to identical treatment without apoE. The fold enhancement by apoE was calculated by determining the EC50 of the dose response curve as calculated with PRISM software.
Results
We previously demonstrated that apoE could enhance lipid antigen presentation to NKT cells by DCs
16
. Since αGalCer has been shown to promote humoral immunity in a
CD1d-dependent manner, we tested whether apoE-delivery of αGalCer to B cells enhances NKT help for B cell proliferation and immunonoglobulin production. Purified tonsillar B cells were cultured with αGalCer and NKT cells in the presence or absence of human apoE. Addition of apoE substantially enhanced both NKT cell and B cell proliferation in response to αGalCer, as shown by expression of the nuclear proliferation antigen Ki67 (Fig. 1A , C and E) and total cell number ( Fig. 1B and D) . In the absence of apoE, αGalCer was ineffective at inducing B cell and NKT cell proliferation even at relatively high concentrations (500ng/ml). With apoE, proliferation was observed with αGalCer concentrations as low as 1ng/ml. This enhancement by apoE did not occur in the absence of antigen, or with controls using non-specific stimuli including B cell agonists (anti-Ig and SAC) or T cells agonists (PHA and anti-CD3) ( Fig. 1 and data not shown).
Next, we analyzed B cell activation and antibody production to assess the influence of apoE on efficient αGalCer presentation. B cells and NKT cells were cocultured with αGalCer in the presence or absence of apoE, and CD86 expression was measured. While αGalCer alone had little effect on B cell CD86 expression, apoE/αGalCer-treated cells expressed 2-4-fold higher levels of CD86 on day 2 and day 4, respectively ( Fig. 2A) . Likewise, antibody production was entirely dependent on apoE /αGalCer (Fig. 2B ). ApoE/αGalCer elicited significantly (7-fold) higher IgG than media, αGalCer, apoE, or B cells only (Fig. 2B , and data not shown). Together, these data suggest that B cells are highly dependent on apoE for efficient uptake of lipid antigens in order to recruit NKT cell help.
The LDL-R is the predominant cell surface receptor that binds apoE and mediates lipoprotein internalization; however, other receptors can also capture apoE. Given that Next, the ability of resting and activated B cells to present αGalCer to NKT cells was compared with or without apoE. We found that B cells activated by either anti-Ig or CD40L were modestly better at presenting free αGalCer than resting B cells. However, the delivery of αGalCer with apoE significantly enhanced their ability to activate NKT cells, shifting the dose response curve 30-fold for anti-Ig and 105-fold for CD40L (versus just 3-fold enhancement for media alone) (Fig. 3B) . Thus, the degree of enhancement by apoE is closely associated with LDL-R expression on B cells.
Although optimal loading of αGalCer onto CD1d requires trafficking through the endosomal-lysosomal pathway prior to presentation to NKT cells, αGalCer does not require processing for loading onto CD1d 20 . Given that protein antigens need to be processed into peptides for MHC loading, it is possible that some pathogen-derived lipid antigens also require processing to generate antigenic lipids for NKT cell presentation.
We investigated the ability of B cells to process lipid antigens by using αGalGalCer, a lipid that requires uptake and processing in lysosomes where it is converted to the NKT agonist αGalCer
20
. Since CD40L-activated B cells were consistently the most potent APCs when assayed in vitro with apoE-αGalCer, we used these in subsequent experiments. Like αGalCer, αGalGalCer completely requires apoE for CD40L-activated B cells to activate NKT cells (Fig. 3C ), indicating that B cells are able to process lipid antigens internalized with apoE.
In order to rule out any effect of apoE directly on T cells, CD40L-activated B cells were pulsed for 4 hours with either αGalCer or αGalGalCer in the presence or absence of apoE, and the cells were then washed prior to incubation with NKT cells. B cells pre-treated with lipid antigen alone did not promote NKT cells activation, whereas
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From addition of apoE allowed B cells to efficiently acquire αGalCer and αGalGalCer for presentation to NKT cells (Fig 3D) . Although we and others have observed that all lymphocytes may up-regulate the LDL-R following activation (not shown) 19 , we found no direct effect when NKT cells were stimulated in the presence of αGalCer and apoE in the absence of B cells (Fig 3D) . Thus, efficient uptake and presentation of αGalCer requires B cell uptake of apoE-bound lipid antigens.
To determine whether uptake of apoE-bound lipid antigens was mediated by the LDL-R we pulsed CD40L-activated B cells with apoE-αGalCer in the presence of LDL-R blocking antibodies. NKT activation was blocked by two LDL-R blocking antibodies and a CD1d blocking antibody, but not by corresponding control antibodies (Fig. 4A) . In order to further implicate LDL-R-mediated uptake, we compared the ability of different apoE isoforms to enhance αGalCer presentation by CD40L-activated B cells. Enhanced
NKT activation was observed with apoE3 and apoE4 but not with apoE2, a variant defective in LDL-R binding (Fig. 4B ) 21, 22 . Importantly, compared to free αGalCer, apoE2 actually diminished αGalCer activity suggesting that apoE2 binds and sequesters the antigen, but is unable to be taken up by the B cells.
Our previous work demonstrated that αGalCer incubated in human serum distributes in the VLDL fraction and that dendritic cell presentation to NKT cells was apoE-dependent. We wished to confirm that B cell uptake of αGalCer from human serum, like purified apoE-bound αGalCer, utilizes the LDL-R pathway. LDL-R-specific antibodies abolished αGalCer stimulation incubated with either total human serum, or purified apoE, but had no effect on the PHA-stimulated control (Fig. 4C ). These findings indicate that αGalCer uptake in B cells from human serum requires the LDL-R.
Discussion
In summary, apoE significantly enhances proliferation and activation of NKT cells induced by B cells, and the reciprocal proliferation and activation of B cells. This enhancement is dependent upon the LDL-R, which is expressed on activated B cells.
Thus, in addition to the BCR-mediated uptake described for specific lipid antigens [12] [13] [14] , B cells can utilize an apolipoprotein-mediated pathway of lipid antigen uptake for presentation to NKT cells. This might be the predominant mechanism used by B cells for the uptake of αGalCer when used as an adjuvant for enhancing antibody responses to Tdependent antigens [8] [9] [10] [11] . While part of this effect can also be attributed to increased priming of antigen -specific Th cells 11 , αGalCer also induces specific antibody production to co-administered T-dependent antigen in the absence of Class II-restricted
Th cells thus demonstrating a role for direct NKT help [8] [9] [10] .
Our previous work demonstrated the role for apoE and the LDL-R in human dendritic cells presenting CD1-restricted antigens 16 . Unlike DCs, however, our current findings indicate that B cells are much more dependent upon apolipoprotein mediated antigen capture and presentation. The degree of augmentation of B cell antigen presentation by apoE (100-250 fold) is substantially greater than the enhancement seen in DCs (up to 50 fold enhancement) 16 and is similar to that seen when antigens are internalized specifically by the BCR 23, 24 . Also, DCs were still able to capture and present lipid antigens associated with apoE2, albeit with a significantly reduced efficiency, while B cells were almost completely unable to present apoE2-bound αGalCer. , are also potential models that will allow us to explore the role of apoE and the LDL-R in anti-microbial responses.
We propose that the LDL-R-mediated pathway for uptake of lipid antigens by B cells provides a mechanism for the adjuvant effects of αGalCer and potentially for the uptake of bacterial-derived lipid antigens or endogenous lipid antigens that have been recently described [1] [2] [3] [4] 28 . By providing polyclonal B cell stimulation, this pathway of innate help could bolster humoral responses to infection. However, without shared antigen specificity, such promiscuous antigen presentation by B cells may also promote 
